scorecardresearch

Pharma

EXCLUSIVE: Pharma giant Bayer is keenly eyeing India's OTC market

EXCLUSIVE: Pharma giant Bayer is keenly eyeing India's OTC market

Jun 30, 2022

Global pharmaceutical and life sciences company Bayer is eyeing the growing market for over-the-counter (OTC) products in India. And has a strategy in place for expansion.

On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.

Dr Reddy's Laboratories settles patent litigation with Indivior Inc, Aquestive Therapeutics

Jun 30, 2022

On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.

Pharma major Novartis to slash 8,000 jobs globally

Pharma major Novartis to slash 8,000 jobs globally

Jun 29, 2022

The job cuts, previously projected by Chief Executive Vas Narasimhan to be in the "single-digit thousands", are part of a restructuring programme the Swiss pharmaceutical group announced in April, targeting savings of at least $1 billion by 2024.

SEBI issues warning to Aurobindo Pharma over ongoing USFDA audit

SEBI issues warning to Aurobindo Pharma over ongoing USFDA audit

Jun 27, 2022

The Sebi warning letter observes that the company had ''disclosed very limited and restricted information'' and that it did not disclose the detailed reasons and neither considered USFDA's observations as serious.

Dr Reddy's Lab inks settlement pact with Indivior, Aquestive

Dr Reddy's Lab inks settlement pact with Indivior, Aquestive

Jun 24, 2022

The said agreement resolves all claims between the parties relating to the company's products and also covers Indivior's and Aquestive's patent infringement allegations, Dr Reddy's Laboratories said in a regulatory filing.

Dr Reddy’s to acquire injectable product portfolio from Eton Pharma for $50 mn

Dr Reddy’s to acquire injectable product portfolio from Eton Pharma for $50 mn

Jun 24, 2022

The acquisition will support Dr. Reddy's efforts to speed up and increase patient access to affordable medications, the company’s statement read.

Biocon clarified that it was seeking waiver of Phase 3 Clinical Trials for Insulin Aspart in India based on the regulatory guidance only.

Will bribery case impact Biocon's business? Expert weighs in

Jun 23, 2022

"Industry insiders and investors will probably not be rattled by the news as was evidenced by Biocon share price being largely unaffected by the charge, " said analyst Salil Kallianpur.

Aster DM Healthcare to pump in Rs 500 cr to establish super-specialty hospital in Kerala

Aster DM Healthcare to pump in Rs 500 cr to establish super-specialty hospital in Kerala

Jun 17, 2022

The planned facility will house several centres for clinical excellence that will cater to the functions of cardiac sciences, organ transplant, neurosciences, orthopaedics, oncology, urology and nephrology, gastro sciences, and woman and child wellness.

Central government-backed UHI is an open network designed to enable interoperable digital health service delivery.  

EXCLUSIVE: E-commerce, payment platforms to be integrated with Unified Health Interface under Ayushman Bharat, says NHA

Jun 17, 2022

After integration of these platforms with UHI, users can avail a large number of health services like tele-consultation with a doctor, availing services of a lab, transferring test reports or health records digitally to the doctor and paying digitally for any of the above services.

It further claimed that the vaccine induced higher neutralising antibody responses than those observed in adults in whom the efficacy has already been demonstrated

Bharat Biotech’s Covaxin displays robust immune response in children aged between 2-18 yrs, says The Lancet 

Jun 17, 2022

The journal said that the domestically developed vaccine is “safe, well-tolerated and immunogenic in pediatric subjects.” Bharat Biotech confirmed the development in a tweet. 

Govt panel recommends market authorisation for Serum's cervical cancer vaccine

Govt panel recommends market authorisation for Serum's cervical cancer vaccine

Jun 15, 2022

SII manufactures India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer.

Cipla, DNDi launch antiretroviral treatment for young children with HIV in South Africa (Photo: Reuters)

Cipla, DNDi launch antiretroviral treatment for young children with HIV in South Africa

Jun 14, 2022

According to Cipla, this new formulation does not require refrigeration, has a sweet taste and is easy to administer to infants and children of different weights and ages.

ASG Eye Hospital the strongest bidder for acquiring Vasan Eye Care network

ASG Eye Hospital plans to revive Vasan Eye care post acquisition 

Jun 14, 2022

ASG has been on an acquisition spree through the pandemic and has recently acquired two sizeable chains in North India, emerging as a significant healthcare platform.

It remains unclear how many parents will get their young ones vaccinated as demand has been low for kids aged 5 to 11.

COVID-19: Pfizer vaccines safe for small children, says FDA

Jun 13, 2022

The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.

AZIDO impurity levels observed to be above acceptable limits, the US health regulator noted.

Strides Pharma recalls over 6 lakh bottles of blood pressure treatment tablets in US

Jun 12, 2022

As per the latest enforcement report by USFDA, the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure lowering drug in the US market.

For the last two years, RIL has been expanding its presence in the pharma and health sector and trying to establish a firm base in the segment.

RIL’s pharma portfolio to expand with potential Boots Pharma chain deal

Jun 10, 2022

RIL and Apollo Global Management together have made an offer for Walgreens Boots Alliance’s Boots business that makes them the strongest bidder for the deal.

Strides Pharma Inc will market the product in the American market, as per an exchange filing.  

Strides Pharma receives FDA approval for Ibuprofen suspension 

Jun 10, 2022

US market for the suspension is pegged at around $41 million and this product will be manufactured at the company’s facility at Bengaluru. 

Representational Image

Alembic Pharma gets tentative USFDA approval for its Dasatinib tablets

Jun 10, 2022

Dasatinib tablets are used for the treatment of adult patients with leukaemia-related ailments.


Lupin bags tentative approval from US FDA for Ivacaftor Tablets (Photo: Reuters)

Lupin bags tentative approval from US FDA for Ivacaftor Tablets

Jun 08, 2022

As per the company, the product will be manufactured at Lupin’s Nagpur facility in India

Serum Institute to manufacture COVID-19 vaccine for US

Serum Institute to manufacture COVID-19 vaccine for US: Novavax

Jun 08, 2022

Novavax said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the Serum Institute of India.

Zydus gets USFDA approval to market generic acne drug

Zydus gets USFDA approval to market generic acne drug

Jun 07, 2022

Zydus Lifesciences announced receiving final approval from the US health regulator to commercialize the drug with a market size of $195 million.